Catalyst Wire Dossier Catalyst Wire Dossier

AMNESTEEM

isotretinoin · Mylan Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

22 regulatory and trial events tracked for AMNESTEEM, covering 2007-02-06 to 2026-08-21. Get the full timeline:

Most recent: FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)

See pricing